# Genmedica

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/genmedica

- Industry: Biotechnology
- Headquarters: Barcelona, Spain
- Website: www.genmedica.com
- Total disclosed funding: $2.1M
- Latest round: Series B (Oct 31, 2014)
- Investors on record: 2

## About

Genmedica specializes in the sale and leasing of premium domain names, focusing on secure transactions and flexible options for clients. It offers a global service to businesses establishing their online presence.Genmedica, founded in 2004 and headquartered in Barcelona, Spain, is focused on the domain name market, providing both sales and leasing options. The company has undergone strategic operations since its founding but has not reported any significant pivots. It has completed a total of 5 deals, with the most recent deal occurring on October 31, 2014, when Genmedica raised EUR 1.7 million in SERIES B financing co-led by Caixa Capital Risc and ICF Capital, totaling EUR 1.7 million raised. The founder's specific background is not publicly documented.GenMedica.com specializes in the sale and leasing of premium domain names, offering a wide range of domain names for outright purchase or lease-to-own arrangements. Clients can acquire domains for a one-time fee or choose a monthly payment plan, catering to small businesses, entrepreneurs, and various organizations. The company serves a diverse clientele across North America, Europe, and Asia, focusing on facilitating safe and secure transactions and addressing the challenges of acquiring desirable online identities.GenMedica.com generates revenue through the sale and leasing of domain names, with prices structured around direct-to-consumer sales. Customers can purchase a domain outright for EUR 4,295 or opt for a lease-to-own plan at EUR 364 per month, offering a clear pricing model. The company also provides additional support services to enhance the transaction process, reinforcing its reputation for safe and efficient domain transfers. The EBITDA for the most recent year, 2017, was EUR -320,909.80.Genmedica aims to leverage its latest funding from the SERIES B financing to expand its offerings and improve its market presence. The company has plans to introduce new premium domain name options and enhance its user interface for better customer interaction. Moreover, Genmedica intends to target expansion into emerging markets in Asia and South America within the next 2-3 years to diversify its clientele further and increase revenue streams.

## Funding rounds

- Series B, Oct 31, 2014, $2.1M — Caixa Capital Risc, ICF Capital

## Investors

- Caixa Capital Risc — Series B
- ICF Capital (https://capitalatlas.ai/funds/icf-capital) — Series B